These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 9814682)

  • 1. Treatment of antiphospholipid syndrome in pregnancy.
    Cowchock S
    Lupus; 1998; 7 Suppl 2():S95-7. PubMed ID: 9814682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of thrombosis and pregnancy loss in the antiphospholipid syndrome.
    Khamashta MA
    Lupus; 1998; 7 Suppl 2():S162-5. PubMed ID: 9814696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of fetal death in the antiphospholipid antibody syndrome.
    Cowchock S
    Lupus; 1996 Oct; 5(5):467-72. PubMed ID: 8902784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies.
    Triolo G; Ferrante A; Ciccia F; Accardo-Palumbo A; Perino A; Castelli A; Giarratano A; Licata G
    Arthritis Rheum; 2003 Mar; 48(3):728-31. PubMed ID: 12632426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin.
    Backos M; Rai R; Baxter N; Chilcott IT; Cohen H; Regan L
    Br J Obstet Gynaecol; 1999 Feb; 106(2):102-7. PubMed ID: 10426674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based treatment of the antiphospholipid syndrome: I. Pregnancy failure.
    Wisløff F; Crowther M
    Thromb Res; 2004; 114(2):75-81. PubMed ID: 15306148
    [No Abstract]   [Full Text] [Related]  

  • 7. Heparin or aspirin or both in the treatment of recurrent abortions in women with antiphospholipid antibody (syndrome).
    Hoppe B; Burmester GR; Dörner T
    Curr Opin Rheumatol; 2011 May; 23(3):299-304. PubMed ID: 21346577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiphospholipid syndrome in obstetrics.
    Heilmann L; von Tempelhoff GF; Pollow K
    Clin Appl Thromb Hemost; 2003 Apr; 9(2):143-50. PubMed ID: 12812384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and safety of rituximab in the treatment of primary antiphospholipid syndrome: analysis of 24 cases from the bibliography review].
    Pons I; Espinosa G; Cervera R
    Med Clin (Barc); 2015 Feb; 144(3):97-104. PubMed ID: 24698717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IVIG in APS pregnancy.
    Triolo G; Ferrante A; Accardo-Palumbo A; Ciccia F; Cadelo M; Castelli A; Perino A; Licata G
    Lupus; 2004; 13(9):731-5. PubMed ID: 15485113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of patients with antiphospholipid antibodies during pregnancy.
    Many A; Pauzner R; Carp H; Langevitz P; Martinowitz U
    Am J Reprod Immunol; 1992; 28(3-4):216-8. PubMed ID: 1285882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.
    Laskin CA; Spitzer KA; Clark CA; Crowther MR; Ginsberg JS; Hawker GA; Kingdom JC; Barrett J; Gent M
    J Rheumatol; 2009 Feb; 36(2):279-87. PubMed ID: 19208560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-molecular-weight heparin versus intravenous immunoglobulin for recurrent abortion associated with antiphospholipid antibody syndrome.
    Dendrinos S; Sakkas E; Makrakis E
    Int J Gynaecol Obstet; 2009 Mar; 104(3):223-5. PubMed ID: 19116178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late puerperal thrombohemorrhagic complications in a patient with antiphospholipid syndrome.
    Bladt V; Steengaard-Pedersen K; Poulsen LH; Petersen OB; Laursen B; d'Amore F
    Eur J Haematol; 2004 Dec; 73(6):437-40. PubMed ID: 15522067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for managing heparin therapy in patients with antiphospholipid antibody syndrome.
    Mehta TP; Smythe MA; Mattson JC
    Pharmacotherapy; 2011 Dec; 31(12):1221-31. PubMed ID: 22122183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment outcome in women suffering from recurrent miscarriages and antiphospholipid syndrome].
    Malinowski A; Dyński MA; Maciołek-Blewniewska G; Głowacka E; Pawłowski T; Babula G
    Ginekol Pol; 2003 Oct; 74(10):1213-22. PubMed ID: 14669420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of pregnant patients with antiphospholipid syndrome.
    Cervera R; Balasch J
    Lupus; 2004; 13(9):683-7. PubMed ID: 15485103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid syndrome: definition and treatment.
    Galli M; Barbui T
    Semin Thromb Hemost; 2003 Apr; 29(2):195-204. PubMed ID: 12709923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectivity of heparin in assisted reproduction.
    Fiedler K; Würfel W
    Eur J Med Res; 2004 Apr; 9(4):207-14. PubMed ID: 15210401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of unfractionated and low molecular weight heparin on antiphospholipid antibody binding in vitro.
    Franklin RD; Kutteh WH
    Obstet Gynecol; 2003 Mar; 101(3):455-62. PubMed ID: 12636948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.